Veteran medical device analyst Mike Weinstein at JPMorgan is out with a pretty remarkable research note about the fast-changing market for drug-coated stents. Not too long ago, some had written off the potential for significant growth to resume in sales of the little wire mesh tubes that are painted with special drugs to help keep arteries from reclogging.
Discuss   Add this link to...  Bury

Comments Who Voted Related Links